Podcast thumbnail for Episode 1 - Aggregation play for pharmaceutical companies by Vaibhav Manek

Episode 1 - Aggregation play for pharmaceutical companies by Vaibhav Manek

Claim This Podcast

by KNAV

3 episodes
Updated Daily
Accepts GuestsHas Sponsors

Podcast Overview

Vaibhav Manek, Partner – KNAV, comments on how pharma companies should consider aggregation as a strategy for growth and attracting fresh investments.

Language

🇺🇲

Publishing Since

8/17/2020

1 verified contact email on file for Episode 1 - Aggregation play for pharmaceutical companies by Vaibhav Manek

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for High Tax Exception Podcast by Shishir Lagu

October 19, 2020

High Tax Exception Podcast by Shishir Lagu

<p>This podcast deals with potential tax benefit brought about by the recently enacted High Tax Exception (HTE) under Global Intangible Low Tax Income, commonly referred to as GILTI. The GILTI provisions introduced by TCJA were unintentionally penalising US taxpayers with domestic losses but having profitable controlled foreign corporations in jurisdictions having tax rates higher than that of the US. The GILTI HTE has brought about some much-awaited relief for such taxpayers.</p>

Episode thumbnail for Episode 2 - Capital Raise for Tech Companies by Vaibhav Manek

September 9, 2020

Episode 2 - Capital Raise for Tech Companies by Vaibhav Manek

<p>Vaibhav Manek, Partner – KNAV, comments on the fundraising environment for technology businesses and the nuances of tech scale up with capital.</p>

Episode thumbnail for Episode 1 - Aggregation Play for Pharmaceutical Companies

August 17, 2020

Episode 1 - Aggregation Play for Pharmaceutical Companies

<p>Vaibhav Manek, Partner – KNAV, comments on how pharma companies should consider aggregation as a strategy for growth and attracting fresh investments.</p>

3 total episodes available

Deep-dive analytics for Episode 1 - Aggregation play for pharmaceutical companies by Vaibhav Manek

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is Episode 1 - Aggregation play for pharmaceutical companies by Vaibhav Manek?

Vaibhav Manek, Partner – KNAV, comments on how pharma companies should consider aggregation as a strategy for growth and attracting fresh investments.

How often does this podcast release new episodes?

This podcast updates daily.

Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

No, this podcast does not typically feature guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.